Skip to content

Novel NRTI backbone effective

International AIDS Society chief signals aggressive commitment to treatment access

Women at greatest risk of NNRTI rash

Growth hormone reduces fat accumulation

ACTG 384: Major HAART strategy trial a closing day highlight in Barcelona

Scaling up antiretroviral therapy: lessons from Brazil

Why $10 billion for AIDS?

Merck unveils integrase inhibitor

Antiretroviral access: experience from Haiti